The introduction of CHARGE syndrome‐associated mutations in the ATP‐dependent chromatin remodeling and chromodomains of CHD7, tested in nucleosome remodeling assays, provided proof that chromatin remodeling activity is central to the pathogenesis of CHARGE syndrome (Bouazoune & Kingston, 2012). This evidence concerns the gene CHD7 and CHARGE syndrome.